Leithner, K <br/><br/>
PCK2 activation mediates an adaptive response to glucose depletion in lung cancer.  [electronic resource] 

 -  Oncogene  Feb 2015 
 - 1044-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2014.47  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinase Kinases<br/>Adaptation, Physiological--genetics<br/>Carcinoma, Non-Small-Cell Lung--metabolism<br/>Dose-Response Relationship, Drug<br/>Gluconeogenesis--genetics<br/>Glucose--deficiency<br/>Humans<br/>Lung Neoplasms--metabolism<br/>Phosphoenolpyruvate Carboxykinase (ATP)--genetics<br/>Protein Serine-Threonine Kinases--genetics<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>Tumor Cells, Cultured<br/>Tumor Suppressor Protein p53--genetics<br/>ras Proteins--genetics